QQ客服 官方微博 反馈留言

	A multicenter survey of first-line treatment patterns and gene aberration test status of patients with unresectable Stage IIIB/IV nonsquamous non-small cell lung cancer in China (CTONG 1506)
	Zhou, Qing; Song, Yong; Zhang, Xin; Chen, Gong-Yan; Zhong, Dian-Sheng; Yu, Zhuang; Yu, Ping; Zhang, Yi-Ping; Chen, Jian-Hua; Hu, Yi
刊名	BMC Cancer
	2017
卷号	17期号:1页码:462
关键词	Chemotherapy China Epidermal growth factor receptor First-line anticancer treatment Non-small cell lung cancer Tyrosine kinase inhibitor
ISSN号	1471-2407
DOI	10.1186/s12885-017-3451-x
URL标识	查看原文
WOS记录号	WOS:000405012600002;PMID:28673332
内容类型	期刊论文
URI标识	http://www.corc.org.cn/handle/1471x/3341878
专题	中南大学
作者单位	1.[Wu, Yi-Long 2.Zhou, Qing] Guangdong Gen Hosp, Guangdong Lung Canc Inst, 106 Zhongshan 2nd Rd, Guangzhou 510080, Guangdong, Peoples R China.
推荐引用方式 GB/T 7714	Zhou, Qing,Song, Yong,Zhang, Xin,et al. A multicenter survey of first-line treatment patterns and gene aberration test status of patients with unresectable Stage IIIB/IV nonsquamous non-small cell lung cancer in China (CTONG 1506)[J]. BMC Cancer,2017,17(1):462.
APA	Zhou, Qing.,Song, Yong.,Zhang, Xin.,Chen, Gong-Yan.,Zhong, Dian-Sheng.,...&Wu, Yi-Long*.(2017).A multicenter survey of first-line treatment patterns and gene aberration test status of patients with unresectable Stage IIIB/IV nonsquamous non-small cell lung cancer in China (CTONG 1506).BMC Cancer,17(1),462.
MLA	Zhou, Qing,et al."A multicenter survey of first-line treatment patterns and gene aberration test status of patients with unresectable Stage IIIB/IV nonsquamous non-small cell lung cancer in China (CTONG 1506)".BMC Cancer 17.1(2017):462.

个性服务

查看访问统计

相关权益政策

暂无数据

收藏/分享

除非特别说明，本系统中所有内容都受版权保护，并保留所有权利。